Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,780 | -63,675 | -57,924 | -50,315 | -15,619 |
| Depreciation Amortization | 3,549 | 3,046 | 2,526 | 3,025 | 2,628 |
| Accounts payable and accrued liabilities | -578 | 393 | -561 | 1,261 | 123 |
| Other Working Capital | -5,459 | -3,219 | -788 | -22 | -1,387 |
| Other Operating Activity | 14,123 | 11,744 | 10,941 | 6,810 | 259 |
| Operating Cash Flow | $-59,145 | $-51,711 | $-45,806 | $-39,241 | $-13,996 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,122 | -2,442 | -2,324 | -2,269 | -921 |
| Net Acquisitions | -760 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -86,278 | -112,892 | -186,591 | -221,795 | -68,359 |
| Sale Of Investment | 155,410 | 71,599 | 163,175 | 85,100 | 44,001 |
| Investing Cash Flow | $66,250 | $-43,735 | $-25,740 | $-138,964 | $-25,279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 335,409 | N/A |
| Common Stock Issued | 1,144 | 368 | 562 | 167 | 42 |
| Other Financing Activity | 0 | 0 | 0 | -8,129 | 75,857 |
| Financing Cash Flow | $1,144 | $368 | $562 | $327,447 | $75,899 |
| Beginning Cash Position | 20,399 | 115,477 | 186,461 | 37,219 | 595 |
| End Cash Position | 28,648 | 20,399 | 115,477 | 186,461 | 37,219 |
| Net Cash Flow | $8,249 | $-95,078 | $-70,984 | $149,242 | $36,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,145 | -51,711 | -45,806 | -39,241 | -13,996 |
| Capital Expenditure | -2,122 | -2,442 | -2,324 | -2,269 | -921 |
| Free Cash Flow | -61,267 | -54,153 | -48,130 | -41,510 | -14,917 |